<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT934-3825</title>
	</head>
	<body>
		<main>
			<p>931207 FT  07 DEC 93 / International Company News: Biotech companies form alliance CellPro and Corange, two international biotechnology companies, have formed an alliance under which Corange will pay up to Dollars 220m for a 15 per cent stake in CellPro and rights to certain products. Bermuda-based Corange, parent of Boehringer Mannheim and De Puy, is the world's second largest producer of in-vitro diagnostic products. CellPro, based in Bothwell, Washington, specialises in cell-selection systems for use in therapeutic, diagnostic and research applications. The equity agreement provides for Corange to invest Dollars 110m in CellPro by buying new shares in the company in two tranches over the next 15 months. The agreement will leave it holding approximately 15 per cent of the company's equity. Under separate agreements, Corange will acquire certain rights to therapeutic and diagnostic products being developed by CellPro in return for a signing fee of Dollars 10m, contributions to research and development of up to Dollars 55m, and milestone payments of up to Dollars 45m. One agreement will provide for CellPro and Corange jointly to develop and market stem cell-selection products for therapeutic applications outside North America, and to share profits.</p>
		</main>
</body></html>
            